While IL-17 is pro-osteoclastogenic in arthritis [35-37], IL-4 and IL-13 inhibit osteoclastic differentiation by activation of receptors that decrease RANK formation and by activation of receptors on osteoblasts that decrease RANKL expression but increase osteoprotegerin formation [36,38]. This evidence concerns the gene TNFRSF11B and Arthritis.